Monocytes and neutrophils from tuberculosis patients are insensitive to anti-inflammatory effects triggered by the prototypic formyl peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) Article

Beigier-Bompadre, M, Aleman, M, Barrionuevo, P et al. (2003). Monocytes and neutrophils from tuberculosis patients are insensitive to anti-inflammatory effects triggered by the prototypic formyl peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP) . CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 133(2), 267-274. 10.1046/j.1365-2249.2003.02212.x

Open Access

cited authors

  • Beigier-Bompadre, M; Aleman, M; Barrionuevo, P; Franco, MC; Rubel, CJ; Sasiain, MD; Palermo, MS; Abbate, E; Isturiz, MA

sustainable development goals

authors

publication date

  • August 1, 2003

published in

keywords

  • ACTIVATION
  • ALPHA TNF-ALPHA
  • EXPRESSION
  • IGG1
  • INFECTION
  • Immunology
  • Life Sciences & Biomedicine
  • MYCOBACTERIUM-TUBERCULOSIS
  • PATHOGENESIS
  • RESPONSES
  • STIMULATED MONOCYTES
  • Science & Technology
  • T-CELLS
  • formyl peptides
  • leucocytes
  • tuberculosis

Digital Object Identifier (DOI)

publisher

  • WILEY

start page

  • 267

end page

  • 274

volume

  • 133

issue

  • 2